 Connection
Paul Bunn to Skin Neoplasms
This is a "connection" page, showing publications Paul Bunn has written about Skin Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.424 |
|
|
|
-
Bunn PA, Foss FM. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl. 1996; 24:12-23.
Score: 0.077
-
Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995 Oct; 9(5):1089-107.
Score: 0.076
-
Bunn PA. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy? Arch Dermatol. 1995 May; 131(5):603-5.
Score: 0.074
-
Bunn PA, Hoffman SJ, Norris D, Golitz LE, Aeling JL. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the S?zary syndrome). Ann Intern Med. 1994 Oct 15; 121(8):592-602.
Score: 0.071
-
Bunn PA. Cutaneous T cell lymphomas. BMJ. 1994 Feb 26; 308(6928):551-2.
Score: 0.068
-
Kemme DJ, Bunn PA. State of the art therapy of mycosis fungoides and S?zary syndrome. Oncology (Williston Park). 1992 Feb; 6(2):31-42; discussion 44, 47-8.
Score: 0.059
-
Bunn PA, Norris DA. The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas. J Invest Dermatol. 1990 Dec; 95(6 Suppl):209S-212S.
Score: 0.054
-
Roenigk HH, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Variakojis D, Kaul K, Bunn PA, et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol. 1990 Dec; 95(6 Suppl):198S-205S.
Score: 0.054
-
Bunn PA, Pacheco T. Lessons learned from the systematic evaluation of cutaneous T-cell lymphomas at the national cancer institute and the roadmap for future studies. Clin Lymphoma Myeloma Leuk. 2010 Sep; 10 Suppl 2:S74-9.
Score: 0.054
-
Kaplan EH, Rosen ST, Norris DB, Roenigk HH, Saks SR, Bunn PA. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):208-12.
Score: 0.051
-
Bunn PA, Ihde DC, Foon KA. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas. Int J Cancer Suppl. 1987; 1:9-13.
Score: 0.042
-
Foon KA, Bunn PA. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia. Semin Oncol. 1986 Dec; 13(4 Suppl 5):35-9.
Score: 0.041
-
Foon KA, Roth MS, Bunn PA. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):35-42.
Score: 0.041
-
Bunn PA, Ihde DC, Foon KA. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer. 1986 Apr 15; 57(8 Suppl):1689-95.
Score: 0.040
-
Bunn PA, Foon KA. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A). Semin Oncol. 1985 Dec; 12(4 Suppl 5):18-24.
Score: 0.039
-
Rosen ST, Radvany R, Roenigk H, Terasaki PI, Bunn PA. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985 Mar; 12(3):531-4.
Score: 0.037
-
Bunn PA, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med. 1984 Oct; 101(4):484-7.
Score: 0.036
-
Winkler CF, Bunn PA. Cutaneous T-cell lymphoma: a review. Crit Rev Oncol Hematol. 1983; 1(1):49-92.
Score: 0.031
-
Posner LE, Fossieck BE, Eddy JL, Bunn PA. Septicemic complications of the cutaneous T-cell lymphomas. Am J Med. 1981 Aug; 71(2):210-6.
Score: 0.029
-
Haynes BF, Metzgar RS, Minna JD, Bunn PA. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28; 304(22):1319-23.
Score: 0.028
-
Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980 Aug; 93(2):223-30.
Score: 0.027
-
Bunn PA, Carney DN. Treatment of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):383-7.
Score: 0.026
-
Carney DN, Bunn PA. Manifestations of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):369-77.
Score: 0.026
-
Lamberg SI, Bunn PA. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979 Sep; 115(9):1103-5.
Score: 0.025
-
Bunn PA, Fischmann AB, Schechter GP, Kumar PP, Ihde DC, Cohen MH, Fossieck BE, Gazdar AF, Matthews MJ, Eddy JL, Minna JD. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):713-7.
Score: 0.024
-
Gazdar AF, Carney DN, Russell EK, Schechter GP, Bunn PA. In vitro growth of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):587-90.
Score: 0.024
-
Lamberg SI, Bunn PA. Proceedings of the Workshop on Cutaneous T-Cell Lymphomas (Mycosis Fungoides and S?zary Syndrome). Introduction. Cancer Treat Rep. 1979 Apr; 63(4):561-4.
Score: 0.024
-
Bunn PA, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):725-8.
Score: 0.024
-
Mulshine JL, Carrasquillo JA, Weinstein JN, Keenan AM, Reynolds JC, Herdt J, Bunn PA, Sausville E, Eddy J, Cotelingam JD, et al. Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma. Cancer Res. 1991 Jan 15; 51(2):688-95.
Score: 0.014
-
Kuzel TM, Gilyon K, Springer E, Variakojis D, Kaul K, Bunn PA, Evans L, Roenigk HH, Rosen ST. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):203-7.
Score: 0.013
-
Kohn EC, Steis RG, Sausville EA, Veach SR, Stocker JL, Phelps R, Franco S, Longo DL, Bunn PA, Ihde DC. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the S?zary syndrome. J Clin Oncol. 1990 Jan; 8(1):155-60.
Score: 0.013
-
Kaye FJ, Bunn PA, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989 Dec 28; 321(26):1784-90.
Score: 0.013
-
Keenan AM, Weinstein JN, Carrasquillo JA, Bunn PA, Reynolds JC, Foon KA, Smarte NC, Ghosh B, Fejka RM, Larson SM, et al. Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma. Cancer Res. 1987 Nov 15; 47(22):6093-9.
Score: 0.011
-
Carrasquillo JA, Mulshine JL, Bunn PA, Reynolds JC, Foon KA, Schroff RW, Perentesis P, Steis RG, Keenan AM, Horowitz M, et al. Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J Nucl Med. 1987 Mar; 28(3):281-7.
Score: 0.010
-
Foon KA, Roth MS, Bunn PA. Interferon therapy of non-Hodgkin's lymphoma. Cancer. 1987 Feb 01; 59(3 Suppl):601-4.
Score: 0.010
-
Dmitrovsky E, Matthews MJ, Bunn PA, Schechter GP, Makuch RW, Winkler CF, Eddy J, Sausville EA, Ihde DC. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol. 1987 Feb; 5(2):208-15.
Score: 0.010
-
Carrasquillo JA, Bunn PA, Keenan AM, Reynolds JC, Schroff RW, Foon KA, Su MH, Gazdar AF, Mulshine JL, Oldham RK, et al. Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody. N Engl J Med. 1986 Sep 11; 315(11):673-80.
Score: 0.010
-
Sausville EA, Worsham GF, Matthews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF, Bunn PA. Histologic assessment of lymph nodes in mycosis fungoides/S?zary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol. 1985 Nov; 16(11):1098-109.
Score: 0.010
-
Averbuch SD, Austin HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med. 1984 Jan 05; 310(1):32-5.
Score: 0.008
-
Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer. 1982 Oct 15; 50(8):1539-53.
Score: 0.008
-
Blatt J, Bunn PA, Carney DD, Reaman G, Soprey P, Poplack DG. Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104.
Score: 0.008
-
Brigham BA, Bunn PA, Horton JE, Schechter GP, Wahl LM, Bradley EC, Dunnick NR, Matthews MJ. Skeletal manifestations in cutaneous T-cell lymphomas. Arch Dermatol. 1982 Jul; 118(7):461-7.
Score: 0.008
-
Posner LE, Robert-Guroff M, Kalyanaraman VS, Poiesz BJ, Ruscetti FW, Fossieck B, Bunn PA, Minna JD, Gallo RC. Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J Exp Med. 1981 Aug 01; 154(2):333-46.
Score: 0.007
-
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7415-9.
Score: 0.007
-
Carney DN, Bunn PA, Schechter GP, Gazdar AF. Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Int J Cancer. 1980 Nov 15; 26(5):535-42.
Score: 0.007
-
Broder S, Bunn PA. Cutaneous T-cell lymphomas. Semin Oncol. 1980 Sep; 7(3):310-31.
Score: 0.007
-
Myrie C, Bunn PA, Edelson RL. A clinico-histopathologic atlas. J Dermatol Surg Oncol. 1980 May; 6(5):391-400.
Score: 0.007
-
Huberman MS, Bunn PA, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD. Hepatic involvement in the cutaneous T-cell lymphomas: results of percutaneous biopsy and peritoneoscopy. Cancer. 1980 Apr 01; 45(7):1683-8.
Score: 0.007
-
Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, Guccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood. 1980 Mar; 55(3):409-17.
Score: 0.006
-
Guccion JG, Fischmann AB, Bunn PA, Schechter GP, Patterson RH, Matthews MJ. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood. Cancer Treat Rep. 1979 Apr; 63(4):565-70.
Score: 0.006
-
Schechter GP, Bunn PA, Fischmann AB, Matthews MJ, Guccion J, Soehnlen F, Munson D, Minna JD. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy. Cancer Treat Rep. 1979 Apr; 63(4):571-4.
Score: 0.006
-
Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):575-80.
Score: 0.006
-
Fischmann AB, Bunn PA, Guccion JG, Matthews MJ, Minna JD. Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the S?zary syndrome. Cancer Treat Rep. 1979 Apr; 63(4):591-6.
Score: 0.006
-
Dodd RC, Winkler CF, Williams ME, Bunn PA, Gray TK. Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med. 1986 Oct; 146(10):1971-2.
Score: 0.003
-
Mitsuya H, Matis LA, Megson M, Bunn PA, Murray C, Mann DL, Gallo RC, Broder S. Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J Exp Med. 1983 Sep 01; 158(3):994-9.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|